Significant Ownership of DEERFIELD MANAGEMENT COMPANY, L.P.

Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by DEERFIELD MANAGEMENT COMPANY, L.P..

Notify me when DEERFIELD MANAGEMENT COMPANY, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of DEERFIELD MANAGEMENT COMPANY, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LRMR Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share 34% $123,052,785 +$17,250,000 35,667,474 +16% Deerfield Management Company, L.P. 27 Feb 2026
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 10% $2,245,157 989,056 Deerfield Management Company, L.P. 09 Feb 2026
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 10% $2,178,182 15,558,445 Deerfield Management Company, L.P. 27 Feb 2025
SPRY ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 7.8% $134,624,739 -$18,102,531 7,610,217 -12% Deerfield Management Company, L.P. 30 Jul 2025

Schedules 13D/G Reported by DEERFIELD MANAGEMENT COMPANY, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.